LONDON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics (AUTL) plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces the online ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback